217 related articles for article (PubMed ID: 17267510)
61. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.
Park J; Lee MS; Yoo SM; Jeong KW; Lee D; Choe J; Seo T
J Virol; 2007 Nov; 81(22):12680-4. PubMed ID: 17855527
[TBL] [Abstract][Full Text] [Related]
62. The prototype gamma-2 herpesvirus nucleocytoplasmic shuttling protein, ORF 57, transports viral RNA through the cellular mRNA export pathway.
Williams BJ; Boyne JR; Goodwin DJ; Roaden L; Hautbergue GM; Wilson SA; Whitehouse A
Biochem J; 2005 Apr; 387(Pt 2):295-308. PubMed ID: 15537388
[TBL] [Abstract][Full Text] [Related]
63. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus.
Lagunoff M; Ganem D
Virology; 1997 Sep; 236(1):147-54. PubMed ID: 9299627
[TBL] [Abstract][Full Text] [Related]
64. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
65. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
66. The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction.
Lim CS; Seet BT; Ingham RJ; Gish G; Matskova L; Winberg G; Ernberg I; Pawson T
Biochemistry; 2007 Sep; 46(35):9874-85. PubMed ID: 17696407
[TBL] [Abstract][Full Text] [Related]
67. A role for herpesvirus saimiri orf14 in transformation and persistent infection.
Duboise M; Guo J; Czajak S; Lee H; Veazey R; Desrosiers RC; Jung JU
J Virol; 1998 Aug; 72(8):6770-6. PubMed ID: 9658125
[TBL] [Abstract][Full Text] [Related]
68. Analysis of nucleotide sequence of the rightmost 43 kbp of herpesvirus saimiri (HVS) L-DNA: general conservation of genetic organization between HVS and Epstein-Barr virus.
Nicholas J; Cameron KR; Coleman H; Newman C; Honess RW
Virology; 1992 May; 188(1):296-310. PubMed ID: 1314457
[TBL] [Abstract][Full Text] [Related]
69. A comparative analysis of the sequence of the thymidine kinase gene of a gammaherpesvirus, herpesvirus saimiri.
Honess RW; Craxton MA; Williams L; Gompels UA
J Gen Virol; 1989 Nov; 70 ( Pt 11)():3003-13. PubMed ID: 2555434
[TBL] [Abstract][Full Text] [Related]
70. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
Conrad NK
Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
[TBL] [Abstract][Full Text] [Related]
71. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation.
Agarwal N; Hardt T; Brero A; Nowak D; Rothbauer U; Becker A; Leonhardt H; Cardoso MC
Nucleic Acids Res; 2007; 35(16):5402-8. PubMed ID: 17698499
[TBL] [Abstract][Full Text] [Related]
72. Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.
Full F; Reuter N; Zielke K; Stamminger T; Ensser A
J Virol; 2012 Apr; 86(7):3541-53. PubMed ID: 22278248
[TBL] [Abstract][Full Text] [Related]
73. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
74. Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators.
Guo YE; Oei T; Steitz JA
J Virol; 2015 Nov; 89(21):10901-11. PubMed ID: 26292323
[TBL] [Abstract][Full Text] [Related]
75. Primary structure of the herpesvirus saimiri genome.
Albrecht JC; Nicholas J; Biller D; Cameron KR; Biesinger B; Newman C; Wittmann S; Craxton MA; Coleman H; Fleckenstein B
J Virol; 1992 Aug; 66(8):5047-58. PubMed ID: 1321287
[TBL] [Abstract][Full Text] [Related]
76. T-cell growth transformation by herpesvirus saimiri is independent of STAT3 activation.
Heck E; Lengenfelder D; Schmidt M; Müller-Fleckenstein I; Fleckenstein B; Biesinger B; Ensser A
J Virol; 2005 May; 79(9):5713-20. PubMed ID: 15827186
[TBL] [Abstract][Full Text] [Related]
77. T-cell transformation and oncogenesis by gamma2-herpesviruses.
Ensser A; Fleckenstein B
Adv Cancer Res; 2005; 93():91-128. PubMed ID: 15797445
[TBL] [Abstract][Full Text] [Related]
78. G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV.
Madireddy A; Purushothaman P; Loosbroock CP; Robertson ES; Schildkraut CL; Verma SC
Nucleic Acids Res; 2016 May; 44(8):3675-94. PubMed ID: 26837574
[TBL] [Abstract][Full Text] [Related]
79. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59.
Albrecht JC; Nicholas J; Cameron KR; Newman C; Fleckenstein B; Honess RW
Virology; 1992 Sep; 190(1):527-30. PubMed ID: 1382344
[TBL] [Abstract][Full Text] [Related]
80. Assessment of infectivity using a Herpesvirus saimiri (HVS) recombinant that expresses HVS-GFP.
Whitehouse A
Cold Spring Harb Protoc; 2011 Dec; 2011(12):1520-3. PubMed ID: 22135663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
